About Eureka Genomics
Eureka Genomics is a company based in Hercules (United States) founded in 2007 was acquired by Affymetrix in May 2015. Eureka Genomics has raised $2.52 million across 2 funding rounds from investors including Affymetrix and United States Department of Agriculture. Eureka Genomics offers products and services including Barley SNP Panel, International Bovine Parentage Panel, and Next Generation Sequencing. Eureka Genomics operates in a competitive market with competitors including Avidity Biosciences, DNAnexus, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
- Headquarter Hercules, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eureka Genomics Corporation
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.52 M (USD)
in 2 rounds
-
Latest Funding Round
$99.78 K (USD), Grant
May 16, 2012
-
Investors
Affymetrix
& 1 more
-
Employee Count
Not available
-
Acquired by
Affymetrix
(May 14, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Eureka Genomics
Eureka Genomics offers a comprehensive portfolio of products and services, including Barley SNP Panel, International Bovine Parentage Panel, and Next Generation Sequencing.
Genomic tool for barley variety analysis in agricultural research.
Testing service for verifying bovine parentage through DNA sequencing.
Platform for DNA sequencing and data analysis in scientific applications.
Funding Insights of Eureka Genomics
Eureka Genomics has successfully raised a total of $2.52M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $99.78 thousand completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Eureka Genomics
Eureka Genomics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Affymetrix and United States Department of Agriculture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Provider of technologies for multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level
|
Locked | Locked | Locked |
Investor details for Eureka Genomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Eureka Genomics
Investment portfolio details for Eureka Genomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Eureka Genomics
Detailed financials for Eureka Genomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Eureka Genomics Comparisons
Peer comparison for Eureka Genomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Eureka Genomics
Eureka Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, DNAnexus, Univercells, Sutro Biopharma and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Cloud-based genome informatics and data management are provided.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
Detailed competitors of Eureka Genomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Eureka Genomics
Complete news archive for Eureka Genomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Eureka Genomics
Eureka Genomics was founded in 2007 and raised its 1st funding round 3 years after it was founded.
Eureka Genomics is headquartered in Hercules, United States. It is registered at Hercules, California, United States.
Eureka Genomics is a funded company, having raised a total of $2.52M across 2 funding rounds to date.
Founded in 2007 and based in Hercules, United States, Eureka Genomics operates in the bioinformatics sector. Sequencing data is analyzed to develop diagnostics for biomarkers related to inherited traits, cancers, and infectious diseases in humans, animals, and the environment. Genetic testing services are provided for ovine, bovine, plants, and human identification. The company was acquired by Affymetrix in 2015.
Eureka Genomics's top competitors include DNAnexus, Sutro Biopharma and Avidity Biosciences.
Eureka Genomics offers Barley SNP Panel, International Bovine Parentage Panel, and Next Generation Sequencing.
Eureka Genomics has 2 investors. Key investors include Affymetrix, and United States Department of Agriculture.